EDGAR Filing Documents for 0001144204-17-052475

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-17-052475

Filing Date

2017-10-13

Accepted

2017-10-13 17:26:58

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	v475709_10k.htm	10-K	1132591
2	EXHIBIT 2.3	v475709_ex2-3.htm	EX-2.3	16712
3	EXHIBIT 23.1	v475709_ex23-1.htm	EX-23.1	2966
4	EXHIBIT 31.1	v475709_ex31-1.htm	EX-31.1	9693
5	EXHIBIT 31.2	v475709_ex31-2.htm	EX-31.2	9666
6	EXHIBIT 32.1	v475709_ex32-1.htm	EX-32.1	4225
7	EXHIBIT 32.2	v475709_ex32-2.htm	EX-32.2	4312
	Complete submission text file	0001144204-17-052475.txt		6282799

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	svon-20170630.xml	EX-101.INS	1342886
9	XBRL TAXONOMY EXTENSION SCHEMA	svon-20170630.xsd	EX-101.SCH	51672
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	svon-20170630_cal.xml	EX-101.CAL	50789
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	svon-20170630_def.xml	EX-101.DEF	356497
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	svon-20170630_lab.xml	EX-101.LAB	437712
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	svon-20170630_pre.xml	EX-101.PRE	406294

Mailing Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121

Business Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121 (858) 909-0749

Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)